Skip to content

GujjuTicks brief

India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand | Reuters

Keep up with the latest medical breakthroughs and healthcare trends with the award-winning Reuters Health Rounds newsletter. Sign up here ... This GujjuTicks brief summarizes the headline for local readers; read the full story on the publisher site.

This is a short GujjuTicks summary for discovery. Full reporting and quotes belong to the original publisher.

Read full story More in India health news Today’s edition